Wave Competitors
| WVE Stock | USD 13.27 0.32 2.35% |
Wave Life vs Amylyx Pharmaceuticals Correlation
Very good diversification
The correlation between Wave Life Sciences and AMLX is -0.29 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Wave Life Sciences and AMLX in the same portfolio, assuming nothing else is changed.
Moving against Wave Stock
As of February 12, 2026, Return On Tangible Assets is expected to decline to -0.26. In addition to that, Return On Capital Employed is expected to decline to -0.55. At present, Wave Life's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.66, whereas Other Assets are forecasted to decline to about 4.1 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Wave Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Wave Life Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Wave Life and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Wave and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Wave Life Sciences does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Wave Stock performing well and Wave Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wave Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | 3.84 | 0.44 | 0.08 | 1.38 | 4.61 | 7.57 | 38.64 | |||
| ZBIO | 5.59 | 0.15 | (0.01) | (0.02) | 11.47 | 9.05 | 68.95 | |||
| UPB | 3.99 | (0.42) | 0.00 | (1.02) | 0.00 | 7.84 | 24.37 | |||
| ELVN | 3.91 | 0.68 | 0.18 | 0.43 | 3.67 | 8.88 | 54.92 | |||
| SYRE | 2.65 | 0.57 | 0.20 | 0.53 | 2.49 | 7.15 | 20.03 | |||
| ORIC | 2.99 | (0.37) | 0.00 | (0.18) | 0.00 | 8.28 | 20.28 | |||
| TERN | 3.96 | 1.32 | 0.38 | (5.85) | 2.51 | 8.22 | 43.41 | |||
| TRML | 2.68 | 1.38 | 0.66 | (1.46) | 0.00 | 6.53 | 58.54 | |||
| NTLA | 4.00 | (0.14) | 0.00 | 0.04 | 5.86 | 10.12 | 23.60 | |||
| AMLX | 3.13 | 0.29 | 0.06 | (6.93) | 3.18 | 8.11 | 22.15 |
Cross Equities Net Income Analysis
Compare Wave Life Sciences and related stocks such as Precigen, Zenas BioPharma Common, and Upstream Bio Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | (85.3 M) | (85.3 M) | (81.9 M) | (39 M) | (81.8 M) | (84.5 M) | (186.6 M) | (117 M) | (509.3 M) | (170.5 M) | (170.5 M) | (92.2 M) | 28.3 M | (95.9 M) | (126.2 M) | (113.6 M) | (119.3 M) |
| UPB | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (23.9 M) | (20.5 M) | (62.8 M) | (56.5 M) | (59.4 M) |
| ELVN | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (11.3 M) | (23.5 M) | (19 M) | (24.7 M) | (37.7 M) | (71.6 M) | (89 M) | (80.1 M) | (76.1 M) |
| SYRE | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (11.3 M) | (21.7 M) | (27.2 M) | (44.3 M) | (78.3 M) | (80.9 M) | (65.8 M) | (83.8 M) | (338.8 M) | (208 M) | (187.2 M) | (177.9 M) |
| ORIC | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (22 M) | (21.4 M) | (26.9 M) | (73.7 M) | (77.7 M) | (89.1 M) | (100.7 M) | (127.8 M) | (115.1 M) | (109.3 M) |
| TERN | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (17.7 M) | (68.8 M) | (29.4 M) | (50.2 M) | (60.3 M) | (90.2 M) | (88.9 M) | (80 M) | (84 M) |
| NTLA | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (12.4 M) | (31.6 M) | (67.5 M) | (85.3 M) | (99.5 M) | (125.6 M) | (259.7 M) | (474.2 M) | (481.2 M) | (519 M) | (467.1 M) | (443.8 M) |
Wave Life Sciences and related stocks such as Precigen, Zenas BioPharma Common, and Upstream Bio Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Wave Life Sciences financial statement analysis. It represents the amount of money remaining after all of Wave Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Wave Life Competitive Analysis
The better you understand Wave Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Wave Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Wave Life's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Wave Life Competition Performance Charts
Five steps to successful analysis of Wave Life Competition
Wave Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Wave Life Sciences in relation to its competition. Wave Life's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Wave Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Wave Life's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Wave Life Sciences, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Wave Life position
In addition to having Wave Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Copper Thematic Idea Now
Copper
Companies involved in production of copper. The Copper theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Copper Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Wave Life Correlation with its peers. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Pharmaceuticals sector continue expanding? Could Wave diversify its offerings? Factors like these will boost the valuation of Wave Life. Anticipated expansion of Wave directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Wave Life data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth (0.56) | Return On Assets | Return On Equity |
Understanding Wave Life Sciences requires distinguishing between market price and book value, where the latter reflects Wave's accounting equity. The concept of intrinsic value - what Wave Life's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Wave Life's price substantially above or below its fundamental value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Wave Life's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.